| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2018 | Routti Jorma | Director | Sale+OE | 6,000 | $59.93 | $359,579.20 | -1.5% | |
| Aug 2, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $63.00 | $2,497,200.88 | -0.3% | |
| Jul 19, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $64.90 | $64,900.00 | -3.0% | |
| Jul 19, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $64.35 | $257,400.00 | -14.4% | |
| Jul 19, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $64.91 | $2,572,781.50 | -0.3% | |
| Jul 9, 2018 | Routti Jorma | Director | Sale+OE | 6,000 | $67.71 | $406,260.00 | -4.4% | |
| Jul 6, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $64.99 | $2,575,765.76 | -0.2% | |
| Jul 3, 2018 | Yu K Peony | Chief Medical Officer | Sale+OE | 15,645 | $65.00 | $1,016,925.00 | -9.6% | |
| Jul 3, 2018 | Schoeneck James A47 | Director | Sale+OE | 7,639 | $65.00 | $496,535.00 | -67.4% | |
| Jun 22, 2018 | Schoeneck James A47 | Director | Sale+OE | 4,361 | $65.00 | $283,465.00 | -54.1% |